http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002127289-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-56 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-56 |
| filingDate | 2001-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c44bc5064b720a2291dedaf9e12fc514 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aebc31fa38733558624846217f5a78d |
| publicationDate | 2002-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2002127289-A1 |
| titleOfInvention | Use of bowman birk inhibitor for the treatment of multiple sclerosis and other autoimmune diseases |
| abstract | The present invention provides a non-toxic therapy and a novel use for Bowman Birk Inhibitor (BBI), as administered in Bowman Birk Inhibitor Concentrate (BBIC), for the treatment of autoimmune diseases in a patient, wherein the disease is characterized by chronic inflammation, such as rheumatoid arthritis; and more particularly for the treatment of those diseases that are characterized by chronic neuroinflammation and/or demyelination, such as Multiple Sclerosis (MS) and Guillain Barre Syndrome (GBS). In addition, the present invention provides methods for using BBI/BBIC to reduce, inhibit, suppress or prevent the chronic inflammation in such patients; and more particularly, to reduce, inhibit, suppress or prevent the chronic neuroinflammation and demyelination that occurs when the patient's nerve tissue is affected by the disease. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008003567-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011111243-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7829277-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3429612-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011229729-A2 |
| priorityDate | 2000-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 332.